An Act relative to menstrual product ingredient disclosure
Senate, October 9, 2025 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill relative to menstrual product ingredient disclosure (Senate, No. 1483),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2641).
Bill Information
Bill Information
- Sponsor:
- Senate Committee on Ways and Means
- Status:
- Referred to House Committee on Ways and Means
Bill History
| Branch | Action | |
|---|---|---|
| 10/9/2025 | Senate | Reported form the committee on Senate Ways and Means |
| 10/9/2025 | Senate | Recommended new draft for S1483 |
| 10/9/2025 | Senate | Order relative to subject matter adopted |
| 10/9/2025 | Senate | Placed in the Orders of the Day for Thursday, October 16, 2025 |
| 10/16/2025 | Senate | Substituted as a new draft for S1483 |
| 10/16/2025 | Senate | Ordered to a third reading |
| 10/16/2025 | Senate | Read third |
| 10/16/2025 | Senate | Passed to be engrossed -see Roll Call #73 (Yeas 39 to Nays 0) |
| 10/20/2025 | House | Read; and referred to the committee on House Ways and Means |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.